Cardiac evaluation in children and adults with Pompe disease sharing the common c.−32-13T>G genotype rarely reveals abnormalities

2008 ◽  
Vol 275 (1-2) ◽  
pp. 46-50 ◽  
Author(s):  
N.A.M.E. van der Beek ◽  
O.I.I. Soliman ◽  
C.I. van Capelle ◽  
M.L. Geleijnse ◽  
W.B. Vletter ◽  
...  
2018 ◽  
Vol 123 (2) ◽  
pp. S21
Author(s):  
Stephanie Austin ◽  
Mugdha Rairikar ◽  
Laura Case ◽  
Lauren Bailey ◽  
Zoheb Kazi ◽  
...  

2015 ◽  
Vol 25 (9) ◽  
pp. 719-724 ◽  
Author(s):  
Olimpia Musumeci ◽  
Andrea Thieme ◽  
Kristl G. Claeys ◽  
Stephan Wenninger ◽  
Rudolf A. Kley ◽  
...  

2017 ◽  
Vol 122 (3) ◽  
pp. 99-107 ◽  
Author(s):  
Mugdha V. Rairikar ◽  
Laura E. Case ◽  
Lauren A. Bailey ◽  
Zoheb B. Kazi ◽  
Ankit K. Desai ◽  
...  

Genes ◽  
2020 ◽  
Vol 11 (2) ◽  
pp. 135 ◽  
Author(s):  
May T. Aung-Htut ◽  
Kristin A. Ham ◽  
Michel C. Tchan ◽  
Sue Fletcher ◽  
Steve D. Wilton

Pompe disease, or glycogen storage disease II is a rare, progressive disease leading to skeletal muscle weakness due to deficiency of the acid α-1,4-glucosidase enzyme (GAA). The severity of disease and observed time of onset is subject to the various combinations of heterozygous GAA alleles. Here we have characterized two novel mutations: c.2074C>T and c.1910_1918del, and a previously reported c.1082C>G mutation of uncertain clinical significance. These mutations were found in three unrelated patients with adult-onset Pompe disease carrying the common c.-32-13T>G mutation. The c.2074 C>T nonsense mutation has obvious consequences on GAA expression but the c.1910_1918del (deletion of 3 amino acids) and c.1082C>G missense variants are more subtle DNA changes with catastrophic consequences on GAA activity. Molecular and clinical analyses from the three patients corresponded with the anticipated pathogenicity of each mutation.


2017 ◽  
Vol 7 ◽  
pp. 90-100 ◽  
Author(s):  
Erik van der Wal ◽  
Atze J. Bergsma ◽  
Joon M. Pijnenburg ◽  
Ans T. van der Ploeg ◽  
W.W.M. Pim Pijnappel

2013 ◽  
Vol 42 (2) ◽  
pp. 1291-1302 ◽  
Author(s):  
A. Dardis ◽  
I. Zanin ◽  
S. Zampieri ◽  
C. Stuani ◽  
A. Pianta ◽  
...  

2021 ◽  
Vol 20 ◽  
pp. 227-236
Author(s):  
Emanuele Buratti ◽  
Paolo Peruzzo ◽  
Luca Braga ◽  
Irene Zanin ◽  
Cristiana Stuani ◽  
...  

2020 ◽  
Author(s):  
Paula Hernandez-Arevalo ◽  
Jose D. Santotoribio ◽  
Rocio Delarosa-Rodriguez ◽  
Antonio Gonzalez-Meneses ◽  
Salvador Garcia-Morillo ◽  
...  

Abstract Background: Pompe disease (PD) is an autosomal recessive metabolic disorder caused by mutations in the acid α-glucosidase gene (GAA) that produces defects in the lysosomal acid α-1,4-glucosidase. We aimed to identify genetic variations and clinical features in Spanish subjects to establish genotype-phenotype correlation.Methods: A total of 2709 subjects who showed symptoms or susceptible signs of PD were enrolled in this observational study. Enzymatic activity was detected by fluorometric techniques and the genetic study was carried out using Next-Generation Sequencing.Results: Fourteen different variants from seventeen patients were identified, four of whom had not been described in the literature previously, including a homozygous variant. In all of them α-glucosidase activity was decreased. Muscle weakness, respiratory distress, exercise intolerance, hypotonia, dysphagia and myalgia were commonly observed in patients. Conclusions: This study report four new mutations that contribute to the mutation spectrum of the GAA gene. We confirm that patients in Spain have a characteristic profile of a European population, with c.-32-13T> G being the most prevalent variant. Furthermore, it was confirmed that the c.236_246delCCACACAGTGC mutation in homozygosis is associated with early disease and a worse prognosis.


Sign in / Sign up

Export Citation Format

Share Document